129
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Ocular pharmacokinetics of 0.45% ketorolac tromethamine

, , , &
Pages 1403-1408 | Published online: 01 Dec 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Pranjal Taskar, Akshaya Tatke & Soumyajit Majumdar. (2017) Advances in the use of prodrugs for drug delivery to the eye. Expert Opinion on Drug Delivery 14:1, pages 49-63.
Read now
Rahul Reddy & Stephen Jae Kim. (2011) Critical appraisal of ophthalmic ketorolac in treatment of pain and inflammation following cataract surgery. Clinical Ophthalmology 5, pages 751-758.
Read now

Articles from other publishers (13)

Yuan Wang, Fei Shen, Weiyang Sun, Qinmei Wang & Xiangyang Zhao. (2022) Bandage contact lens soaked in 0.1% diclofenac to relieve early postoperative pain and foreign body sensation after transepithelial photorefractive keratectomy. European Journal of Ophthalmology 32:6, pages 3321-3327.
Crossref
Akshita Chauhan & Tabassum Khan. (2021) Prodrugs - Current development and applications in ocular drug delivery. Journal of Drug Delivery Science and Technology 66, pages 102836.
Crossref
Patrick M. Hughes & Jie Shen. 2021. Ophthalmic Product Development. Ophthalmic Product Development 15 37 .
Rohit Shetty, Ritika Dalal, Archana Padmanabhan Nair, Pooja Khamar, Sharon D’Souza & Ravish Vaishnav. (2019) Pain management after photorefractive keratectomy. Journal of Cataract and Refractive Surgery 45:7, pages 972-976.
Crossref
Andrzej Grzybowski, Reda Zemaitiene & Lina Mikalauskiene. (2019) Post-cataract Cystoid Macular Oedema Prevention – Update 2019. European Ophthalmic Review 13:1, pages 37.
Crossref
Jie Shen, Guang Wei Lu & Patrick Hughes. (2018) Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations. Pharmaceutical Research 35:11.
Crossref
David F. WoodwardStacey L. WenthurTara L. RudebushShan FanCarol B. Toris. (2016) Prostanoid Receptor Antagonist Effects on Intraocular Pressure, Supported by Ocular Biodisposition Experiments. Journal of Ocular Pharmacology and Therapeutics 32:9, pages 606-622.
Crossref
Vrushali S. Tambe, M.N. Deodhar & Vijayalakshmi Prakya. (2016) LC and LC–MS study for simultaneous determination of tramadol hydrochloride and ketorolac tromethamine in bulk and formulation with their major degradation products. Bulletin of Faculty of Pharmacy, Cairo University 54:1, pages 87-97.
Crossref
Tae Hee Lee, Won Choi, Yong Sok Ji & Kyung Chul Yoon. (2016) Comparison of ketorolac 0.45% versus diclofenac 0.1% for macular thickness and volume after uncomplicated cataract surgery. Acta Ophthalmologica 94:3, pages e177-e182.
Crossref
Afshin ShafieeLyle M. BowmanEddie HouKamran Hosseini. (2013) Aqueous Humor Penetration of Ketorolac Formulated in DuraSite or DuraSite 2 Delivery Systems Compared to Acular LS in Rabbits. Journal of Ocular Pharmacology and Therapeutics 29:9, pages 812-816.
Crossref
Scott D. Schoenberger & Stephen J. Kim. (2013) Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease. International Journal of Inflammation 2013, pages 1-8.
Crossref
Paul L. McCormack. (2011) Ketorolac 0.45% Ophthalmic Solution. Drugs & Aging 28:7, pages 583-589.
Crossref
L. David WaterburyDanielle GalindoLinda VillanuevaCathy NguyenMilan PatelLisa BorbridgeMayssa AttarRhett M. SchiffmanDavid A. Hollander. (2011) Ocular Penetration and Anti-inflammatory Activity of Ketorolac 0.45% and Bromfenac 0.09% Against Lipopolysaccharide-Induced Inflammation. Journal of Ocular Pharmacology and Therapeutics 27:2, pages 173-178.
Crossref